Clinical trials, progression-speed differentiating features and swiftness rule of the innovative targets of first-in-class drugs

Drugs produce their therapeutic effects by modulating specific targets, and there are 89 innovative targets of first-in-class drugs approved in 2004–17, each with information about drug clinical trial dated back to 1984. Analysis of the clinical trial timelines of these targets may reveal the trial-...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ying Hong, Li, Xiao Xu, Hong, Jia Jun, Wang, Yun Xia, Fu, Jian Bo, Yang, Hong, Yu, Chun Yan, Li, Feng Cheng, Hu, Jie, Xue, Wei Wei, Jiang, Yu Yang, Chen, Yu Zong, Zhu, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Problem Solving Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299286/
https://www.ncbi.nlm.nih.gov/pubmed/30689717
http://dx.doi.org/10.1093/bib/bby130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299286/
https://www.ncbi.nlm.nih.gov/pubmed/30689717
http://dx.doi.org/10.1093/bib/bby130

Ejemplares similares